86 results on '"R. Kirk"'
Search Results
2. Palliative care: Steroids to combat fatigue.
3. Targeted therapies: the maths behind combination therapy.
4. Urological cancer: Nerves linked to prostate cancer.
5. From ASCO-gynaecological cancer: Advances in cervical cancer screening and treatment.
6. Immunotherapy: Adoptive cell therapy simplified.
7. Genetics: new classification for endometrial cancer puts genes in POLE position.
8. Haematological cancer: new standard of care?
9. Breast cancer: Circulating tumour DNA the better of the blood biomarkers.
10. Urological cancer: Genetic marker to guide treatment?
11. Genetics: The COGS are turning in breast, ovarian and prostate cancer.
12. Radiotherapy: Sparing early stage patients with Hodgkin lymphoma.
13. Haematological cancer: First randomized study.
14. Urological cancer: More options for prostate cancer.
15. Palliative care: Gaps between ideal and reality.
16. The realities of the Liverpool care pathway.
17. Imaging: Red light warning sign for clear-cell renal cell carcinoma--REDECT reveals imaging biomarker.
18. Haematological cancer: European LeukemiaNet AML genetic classification works.
19. Gastrointestinal cancer: New drug shows promise in refractory colorectal cancer.
20. Haematological cancer: Hit the lymphoma, JAK.
21. Tumour evolution: Evidence points to the existence of cancer stem cells.
22. Targeted therapies: New targets in Burkitt lymphoma?
23. Targeted therapies: the toxic reality of new drugs.
24. Targeted therapies: STAT3 and EGFR target resistance.
25. From ASCO-immunotherapy: programming cancer cell death.
26. Basic research: A close look at PARP-1.
27. Clinical trials: New options for melanoma?
28. Pancreatic cancer: Mouse models link metabolism and deubiquitination with Kras.
29. CNS cancer: Don't hedge(hog) your bets.
30. Genetics: Polyglutamine repeats or cancer?
31. Diagnosis: Dying from a cancer diagnosis.
32. Genetics: Cells line up to be characterized.
33. Oncology trials--the elephant in the room.
34. Genetics: Personalized medicine and tumour heterogeneity.
35. Breast cancer: Resource poor but ingenuity rich.
36. Lung cancer: Maintenance chemotherapy--a stitch in time saves nine?
37. Hematological cancer: a new option for patients with PTCL.
38. Gynecological cancer: DOvE pilots its way to intriguing results.
39. Urological cancer: Cause and effect in prostate cancer.
40. Gastrointestinal cancer: Combine and conquer.
41. Breast cancer: Fast, positive data from neosphere.
42. Patient profiling in breast cancer--is knowledge power?
43. Gastrointestinal cancer: a new dawn for CT scans in colon screening?
44. Disease prevention: Pain killer--cancer preventer.
45. Immunotherapy: a first for first-line therapy in NSCLC.
46. Radiotherapy: stop recurring breast cancer nightmares.
47. Targeted therapies: model reveals addiction to oncogenes.
48. Targeted therapies: A new success for an antiangiogenic?
49. Combination therapy: Can less really be more in melanoma?
50. Targeted therapies: Should we be aghast at the AVAGAST data?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.